Prokaryotics and Basilea enter collaboration to develop a novel broad-spectrum antifungal for severe invasive infections
UNION, N.J., Jan. 7, 2026 /PRNewswire/ — Prokaryotics Inc., a privately-held biopharmaceutical company engaged in the discovery and development of…
